We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summary of quality assurance (QA) visit to West of London Breast Screening Service held on 30 January 2018.
The specification and selection of failsafe batches in the NHS Breast Screening Programme for use by screening office managers and staff.
Guidelines for generating consistent pathological data from breast screening services.
Executive summary of quality assurance visit in outer north-east London held on 10 November 2016.
This process explains how Public Health England (PHE) Screening produces publications for professionals and the public.
Executive summary of the quality assurance (QA) visit to the Milton Keynes NHS breast screening programme on 11 November 2019.
Executive summary of the quality assurance (QA) visit to South Derbyshire and South East Staffordshire NHS breast screening programme on 14 June 2019
Executive summary of quality assurance (QA) visit to Kettering held on 6 July 2017.
Executive summary of quality assurance (QA) visit to Crewe breast screening service held on 28 September 2017.
Guidance for breast screening staff on managing vacuum-assisted procedures on the National Breast Screening System (NBSS).
Executive summary of quality assurance (QA) visit in East Lancashire held on 16 November 2016.
Executive summary of quality assurance (QA) visit to East Cheshire and Stockport Breast Screening Service held on 3 July 2018.
Executive summary of quality assurance (QA) visit to North Midlands held on 22 November 2017.
Executive summary of quality assurance (QA) visit to the London breast screening administration hub held on 15 March 2017.
Procedures to ensure the interval between breast screening and invitation for the next screen is 36 months for all eligible women.
NHSBSP occasional report 1203: national collation of interval cancer data.
This guidance is for pathologists issuing provisional or verbal reports. It aims to help reduce risk of patient mismanagement.
Executive summary of quality assurance (QA) visit to Oxfordshire breast screening programme held on 11 June 2019.
National processes and guidance for the collection and reporting of data in the NHS screening programmes.
Procedures for making copies of letters written by healthcare professionals about screened women.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).